Johnson & Johnson has lifted to over $8.2B its offer to settle thousands of lawsuits by people who claim its baby powder gave them cancer, Bloomberg’s Jef Feeley reports, citing people familiar with the matter. The offer, which is higher than the previous $6.5B bid, signals that the company might have to pay at least $1.7B more to settle all of the claims in the years-long litigation, the author notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- J&J raises baby powder settlement offer to over $8.2B, Bloomberg says
- Johnson & Johnson participates in a conference call with Cantor Fitzgerald
- AC Immune receives second milestone payment for ACI-35.030
- J&J data presents ‘limited downside’ to CG Oncology, says Goldman Sachs
- Johnson & Johnson announces interim data from SunRISe-4 study